user

Central Lung Tumors Eligible for Stereotactic Ablative Radiotherapy (SABR) Trials: Analysis of a Cohort Treated Using MR-Guided SABR

被引：0
|
作者：
Giraud, N. [1 ]
Schneiders, F. L. [1 ]
Palacios, M. A. [1 ]
de Koste, J. R. van Sornsen [1 ]
Sesan, S. [1 ]
机构：
[1] Amsterdam UMC, Amsterdam, Netherlands
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2041
引用
收藏
页码：E20 / E20
页数：1
相关论文
共 50 条
  • [1] Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors
    Chaudhuri, Aadel A.
    Tang, Chad
    Binkley, Michael S.
    Jin, Michelle
    Wynne, Jacob F.
    von Eyben, Rie
    Hara, Wendy Y.
    Trakul, Nicholas
    Loo, Billy W., Jr.
    Diehn, Maximilian
    LUNG CANCER, 2015, 89 (01) : 50 - 56
  • [2] Identifying dosimetric predictors of toxicity in multiple lung tumors treated with stereotactic ablative radiotherapy (SABR)
    Tekatli, H.
    Tetar, S.
    Warner, A.
    Palma, D.
    Verbakel, W.
    Nguyen, T.
    Spoelstra, F.
    Gaede, S.
    Slotman, B.
    Senan, S.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S143 - S143
  • [3] Prognostic role of texture analysis in lung cancer treated with stereotactic ablative radiotherapy (SABR)
    Nardone, V.
    Tini, P.
    Mazzoni, L. N.
    La Penna, A.
    Biondi, M.
    Sebaste, L.
    Carfagno, T.
    Vanzi, E.
    De Otto, G.
    Battaglia, G.
    Pastina, P.
    Carbone, S. F.
    Buonamici, F. Banci
    Pirtoli, L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [4] Stereotactic ablative radiotherapy (SABR) for early-stage central lung tumors: New insights and approaches
    Tekatli, H.
    Spoelstra, F. O. B.
    Palacios, M.
    de Koste, J. van Sornsen
    Slotman, B. J.
    Senan, S.
    LUNG CANCER, 2018, 123 : 142 - 148
  • [5] EARLY DETECTION OF RECURRENCE IN PATIENTS TREATED WITH LUNG STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) USING RADIOMICS
    Kunkyab, Tenzin
    Mou, Benjamin
    Jirasek, Andrew
    Haston, Christina
    Andrews, Jeffrey
    Thomas, Steven
    Hyde, Derek
    RADIOTHERAPY AND ONCOLOGY, 2020, 150 : S31 - S31
  • [6] Toxicities and Survival after Stereotactic Ablative Radiotherapy (SABR) for Centrally Located Lung Tumors
    Atalar, B.
    Mustafayev, T.
    Sio, T.
    Sahin, B.
    Gungor, G.
    Aydin, G.
    Yapici, B.
    Ozyar, E.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S836 - S837
  • [7] Safety and Efficacy of Stereotactic Ablative Radiotherapy (SABR) to Multiple (3 or More) Lung Tumors
    Moding, E. J.
    Maxim, P. G.
    Diehn, M.
    Loo, B. W., Jr.
    Gensheimer, M. F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E482 - E482
  • [8] Imaging follow-up after stereotactic ablative radiotherapy (SABR) for lung tumors
    Lo, Simon S.
    Teh, Bin S.
    Mayr, Nina A.
    Chiang, Stephen B.
    Huang, Zhibin
    Yao, Min
    Machtay, Mitchell
    JOURNAL OF RADIATION ONCOLOGY, 2012, 1 (01) : 11 - 16
  • [9] Dosimetric Impact of Gastrointestinal Tract Variability during Online Adaptive MR-Guided Hypofractionated Stereotactic Ablative Radiotherapy (SABR) to the Pancreas
    Teoh, S.
    George, B.
    Owens, R.
    Bungay, H.
    Maughan, T. S.
    Mukherjee, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E599 - E599
  • [10] Radiomics for Early Detection of Recurrence in Patients Treated with Lung Stereotactic Ablative Radiotherapy (SABR)
    Kunkyab, T.
    Mou, B.
    Jirasek, A.
    Haston, C.
    Andrews, J.
    Thomas, S.
    Hyde, D.
    MEDICAL PHYSICS, 2020, 47 (06) : E436 - E436
12345